Table2 Efficacy comparative analysis between the two groups
SS group (n = 71) | MS group (n = 73) | P value | |
|---|---|---|---|
Primary outcome | |||
Major recurrence | 37 (52.1) | 29 (39.7) | 0.012 |
Retreatment | 8 (11.2) | 5 (6.8) | 0.023 |
Initial treatment failure | 3 (4.2) | 4 (5.5) | 0.067 |
SAH | 1 (1.4) | 1 (1.4) | 0.583 |
Related mortality | 4 (5.6) | 1 (1.4) | 0.457 |
Related morbidity | 2 (2.8) | 1 (1.4) | 0.353 |
Clinical outcome | |||
mRS | |||
3–6 | 5 (7.0) | 1 (1.4) | 0.007 |
2 | 3 (4.2) | 4 (5.5) | 0.175 |
0–1 | 63 (88.7) | 68 (93.1) | 0.034 |
OKM grade C–D | 62 (87.3) | 69 (94.5) | 0.041 |